Team:MIT
From 2014.igem.org
(Difference between revisions)
Line 22: | Line 22: | ||
<tr> | <tr> | ||
</table> | </table> | ||
+ | |||
+ | Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by memory loss, behavioral problems… There is currently no cure for this disease, and existing diagnosis methods leave much to be desired. MIT iGEM 2014 has set out to change this. By detecting molecular biomarkers for AD, such as miRNAs and neurotoxic beta-amyloid plaques, and by regulating the production of beta-amyloid plaques, MIT iGEM hopes to create a dynamic solution for patients with Alzheimer’s disease. Looking ahead, … delivery. | ||
Revision as of 02:40, 15 October 2014
Home | Our Project | Lab Work | Outreach | About Us | Medals |
[Dying Neuron] Neurodegenerative Disease |
[6th] Leading cause of death in the US |
[Vaccine] Current diagnosis and therapeutics are not effective |
MIT iGEM 2014Our wiki is currently under construction, so please bear with us as we continue to update it over the coming weeks. |
||
Requirements | ||
Please be sure to keep these links, your audience will want to find your: |
There are a few wiki requirements teams must follow:
Visit the Wiki How To page for a complete list of requirements, tips and other useful information. |
|
Tips | ||
We are currently working on providing teams with some easy to use design templates.
For a full wiki list, you can visit iGEM 2013 web sites and iGEM 2012 web sites lists. |
This wiki will be your team’s first interaction with the rest of the world, so here are a few tips to help you get started:
|